الشروق التونسية
الشروق التونسية
Ready to play
Ready to play
An international clinical trial has found that the Amivantamab injection is effective in reducing cancer tumors, successfully shrinking or completely hiding the tumors in 43 out of 102 patients, with 15 patients experiencing complete disappearance. This was especially notable in advanced head and neck cancers that had not responded to conventional treatments. The therapy relies on a triple mechanism targeting the "EGFR" protein, the "MET" pathway, and boosting the immune system, and is administered via a subcutaneous injection, making it easy to apply. One patient, Karl Walsh, regained his life after a previous treatment had failed and showed significant progress.
Notice: This Is an AI-Generated Summary
Comments (0)